Publications by authors named "William Brian"

Claim this Profile
D
Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.
Jennifer D Hamilton, Sivan Harel, Brian N Swanson, William Brian, Zhen Chen

Clin Exp Allergy· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers.
Sook Wah Yee, Marilyn M Giacomini, Hong Shen, W Griffith Humphreys, Howard Horng, William Brian

Clin Transl Sci· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.
William Brian, Larry M Tremaine, Million Arefayene, Ruben de Kanter, Raymond Evers

Pharmacogenomics· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).
Larry Tremaine, William Brian, Terrye DelMonte, Stephan Francke, Peter Groenen

Pharmacogenomics· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of omeprazole and genetic polymorphism of CYP2C19 on the clopidogrel active metabolite.
Xavier Boulenc, Nassim Djebli, Juan Shi, Laurent Perrin, William Brian

Drug Metab Dispos· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group.
Scott D Patterson, Nadine Cohen, Maha Karnoub, Sharada Louis Truter, Eileen Emison, Brian Spear, William Brian

Pharmacogenomics· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A.
Sandrine Turpault, William Brian, Robert Van Horn, Alix Santoni, Franck Poitiers

Br J Clin Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.
Carolyne Lieu, Juan Shi, François Donat, Robert Van Horn, William Brian

Clin Pharmacokinet· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis